Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2296PDF: 924HTML: 381 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1750PDF: 1147HTML: 505 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2479PDF: 1067HTML: 2237 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
878PDF: 587HTML: 4044 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3972PDF: 1592HTML: 360 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7966PDF: 2529HTML: 2166Table 1.: 277Table 2.: 290Table 3.: 267Table 4.: 263 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3637PDF: 1371HTML: 2412Fi.1 Gritti.Rambaldi: 262 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2121PDF: 838HTML: 734Table1: patient's characteristics: 247Table 2: profile of each patient: 234 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2690PDF: 1254HTML: 174 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1247PDF: 658Suppl. Files: 154HTML: 546 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1879PDF: 1083HTML: 1892Tables: 222 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1220PDF: 1245Suppl. Files: 607HTML: 114 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
610PDF: 305HTML: 155 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
120PDF: 215Suppl. Files: 38Html: 118Html Suppl. Files: 109 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4676Suppl. Files: 1269PDF: 1171Html: 329 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2021PDF: 1247HTML: 350 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
296PDF: 398Suppl. Files: 81HTML: 192 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3082PDF: 1094HTML: 5668 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2237PDF: 1392HTML: 3520 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2366PDF: 1071HTML: 4993 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1309PDF: 950HTML: 365 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4550PDF: 996HTML: 1372Table1: 271 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2598PDF: 1036HTML: 2289 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4791PDF: 2055HTML: 18225 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2735PDF: 1728HTML: 2463Table1: 275 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
252PDF: 779HTML: 77 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3065PDF: 1455HTML: 3741Untitled: 258Untitled: 261Untitled: 220 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1671PDF: 975HTML: 397 -
WHAT ARE FUNGAL INFECTIONS?
4423PDF: 2517HTML: 27713de Pauw: 296 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2159PDF: 972HTML: 1110 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2142PDF: 1991HTML: 812 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13020PDF: 1770HTML: 4370Cover letter: 278Figure 1: 293







